Track the 我武生物 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 我武生物 has recorded 2 public disclosures. Market capitalisation: €12.4bn. The latest transaction was disclosed on 27 June 2022 (Sale). Among the most active insiders: 胡赓熙. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
我武生物是一家专注于医疗保健和制药领域的公司,在XSHE市场上市。它专注于生物产品的开发和生产。